Event Details

Nanobiotix will host a conference call and webcast featuring Nanobiotix chief executive officer, Laurent Levy, to discuss the new data on patients with primary cutaneous melanoma from the ongoing Phase 1 Study 1100, on Thursday, September  18th, 2025, at 8:00 AM EST / 2:00 PM CET. These results will be presented at the Immunorad conference on September 17.
Audio-only dial-in link: https://register-conf.media-server.com/register/BIcf7d5819d70446639d58b5a5867cf216